Clinical Trials Logo

Anxiety Disorders clinical trials

View clinical trials related to Anxiety Disorders.

Filter by:

NCT ID: NCT00706290 Completed - Depression Clinical Trials

Brief CBT for Anxiety and Advanced Cancer

Start date: April 2007
Phase: Phase 2
Study type: Interventional

RATIONALE: Providing cognitive-behavioral therapy (CBT) may reduce anxiety and improve quality of life of patients with advanced cancer. PURPOSE: To examine the development and pilot testing of a brief cognitive-behavioral therapy intervention to treat anxiety and improve quality of life in patients with advanced cancer. Hypothesis: Patients with anxiety associated with advanced cancer who receive CBT will report significantly fewer anxiety symptoms compared to those in the comparison condition.

NCT ID: NCT00703885 Completed - Anxiety Disorders Clinical Trials

PharmacofMRI (Functional Magnetic Resonance Imaging) of Anxiolytic Medications (Alprazolam)

Start date: January 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to use functional magnetic resonance imaging (fMRI) in healthy controls to examine the acute effects of certain anxiolytic medications on brain function.

NCT ID: NCT00703833 Completed - Clinical trials for Generalized Anxiety Disorder

A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019)

Start date: September 2002
Phase: Phase 2
Study type: Interventional

The study will look at the effectiveness of MK0777 in patients with Generalized Anxiety Disorder.

NCT ID: NCT00703547 Completed - Clinical trials for Depressive Disorder and Anxiety Disorders

A First Time in Human Study of GSK586529 in Healthy Volunteers

Start date: January 28, 2008
Phase: Phase 1
Study type: Interventional

A single blind, randomized, placebo-controlled, crossover study in twenty four healthy male subjects. Subjects will be divided into two cohorts with alternate panel design. The study is investigating the safety, tolerability and pharmacokinetics of single oral escalating doses of GSK586529.

NCT ID: NCT00701675 Completed - Clinical trials for Generalized Anxiety Disorder

Pharmacological Treatment of Generalized Anxiety Disorder in the Elderly

Sert-GAD
Start date: October 2005
Phase: Phase 4
Study type: Interventional

Generalized anxiety disorder (GAD) is a very common disorder in the geriatric population with prevalence rates reaching 7% and even higher rates of 8% among elderly veterans. However, despite such high prevalence treating clinicians are presently forced to address treatment issues in this population without the guidance of scientific data. This proposal aims to begin to address this void. In light of emerging information regarding efficacy of the newer anti anxiety agents, specifically the selective serotonin reuptake inhibitors (SSRIs), in the treatment of young adult GAD patients it is time to prospectively evaluate the safety and efficacy of these medications in the treatment of elderly GAD patients. Therefore, this study will examine the effects and safety of the SSRI sertraline at different doses (50mg and 100mg per day) for older patients with GAD.

NCT ID: NCT00699127 Withdrawn - Anxiety Clinical Trials

Organizing the Information Given to Parents of NICU Infants in Order to Reduce Their Anxiety

Start date: July 2008
Phase: N/A
Study type: Interventional

Being a parent to a premature infant in NICU is an anxious state. Parents ask a lot of questions, and look for information all the time. Organizing the information given to parents could reduce their anxiety. The parents will be divided into two groups: one group will get organized information, by a lecture at the first week of their infant's life, and the other group will not. Of course, questions will be answered all the time. The parents will answer a questionnaire on the first week of the infant's life, and on the last week, just before releasing the infant home.

NCT ID: NCT00688818 Completed - Clinical trials for Major Depressive Disorder

Quetiapine in Co-Morbid Depressive and Anxiety Disorders

Start date: June 2008
Phase: N/A
Study type: Interventional

This multi-centred study will be conducted at three centres. The design will be a randomized, placebo-controlled, parallel-group one. This investigation will evaluate the efficacy of add-on Quetiapine XR (extended release) treatment for patients who meet diagnostic criteria for depressive disorders and one or more comorbid anxiety disorder.

NCT ID: NCT00684541 Completed - Clinical trials for Social Anxiety Disorder

Interpretation Modification Program for Social Phobia

SP Interp
Start date: September 2007
Phase: N/A
Study type: Interventional

Generalized Social Phobia is characterized by severe social anxiety that leads to functional impairment (Schneider et al., 1992). Despite its high prevalence, many individuals do not receive treatment or are unresponsive to current therapies. Thus there is a clear need to continue to develop highly effective and efficient treatments for social phobia. This three year project aims to test a computerized treatment for social phobia in a double-blind, placebo-controlled study designed to modify interpretation biases that may maintain anxiety.

NCT ID: NCT00684320 Completed - Clinical trials for Social Anxiety Disorder

Attention Disengagement Training for Social Phobia

SPAttn
Start date: September 2006
Phase: N/A
Study type: Interventional

Generalized Social Phobia is characterized by severe social anxiety that leads to functional impairment (Schneider et al., 1992). Despite its high prevalence, many individuals do not receive treatment or are unresponsive to current therapies. Thus there is a clear need to continue to develop highly effective and efficient treatments for social phobia. This three year project aims to test a computerized treatment for social phobia in a double-blind, placebo-controlled study designed to modify attention biases that may maintain anxiety.

NCT ID: NCT00676364 Completed - Pain Clinical Trials

Randomized Control Trial of a Topical Anesthetic to Evaluate Pain and Anxiety During Venipuncture

Start date: March 2003
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the amount of anxiety and pain felt by children during procedures that require a needle stick after using a topical anesthetic or placebo cream.